LTC3214083I2 - Kvinolono junginių gamybos būdas - Google Patents

Kvinolono junginių gamybos būdas

Info

Publication number
LTC3214083I2
LTC3214083I2 LTPA2021002C LTPA2021002C LTC3214083I2 LT C3214083 I2 LTC3214083 I2 LT C3214083I2 LT PA2021002 C LTPA2021002 C LT PA2021002C LT PA2021002 C LTPA2021002 C LT PA2021002C LT C3214083 I2 LTC3214083 I2 LT C3214083I2
Authority
LT
Lithuania
Prior art keywords
quinolon
compounds
production
quinolon compounds
Prior art date
Application number
LTPA2021002C
Other languages
English (en)
Original Assignee
Melinta Subsidiary Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Subsidiary Corp. filed Critical Melinta Subsidiary Corp.
Publication of LTPA2021002I1 publication Critical patent/LTPA2021002I1/lt
Publication of LTC3214083I2 publication Critical patent/LTC3214083I2/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/027—Gearboxes; Mounting gearing therein characterised by means for venting gearboxes, e.g. air breathers
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/037—Gearboxes for accommodating differential gearings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H48/00—Differential gearings
    • F16H48/06—Differential gearings with gears having orbital motion
    • F16H48/08—Differential gearings with gears having orbital motion comprising bevel gears
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/0457—Splash lubrication
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/048—Type of gearings to be lubricated, cooled or heated
    • F16H57/0482—Gearings with gears having orbital motion
    • F16H57/0483—Axle or inter-axle differentials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/19—Gearing
    • Y10T74/19642—Directly cooperating gears
    • Y10T74/19688—Bevel
    • Y10T74/19693—Motor vehicle drive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/21—Elements
    • Y10T74/2186—Gear casings
    • Y10T74/2188—Axle and torque tubes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
LTPA2021002C 2008-09-24 2021-02-17 Kvinolono junginių gamybos būdas LTC3214083I2 (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24
PCT/US2009/005276 WO2010036329A2 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds
EP09816565.7A EP2346855B1 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds

Publications (2)

Publication Number Publication Date
LTPA2021002I1 LTPA2021002I1 (lt) 2021-03-10
LTC3214083I2 true LTC3214083I2 (lt) 2022-06-27

Family

ID=42060333

Family Applications (3)

Application Number Title Priority Date Filing Date
LTEP20191961.0T LT3766876T (lt) 2008-09-24 2009-09-23 Farmacinė vaisto forma, turinti chinolono darinį
LTEP17163383.7T LT3214083T (lt) 2008-09-24 2009-09-23 Kvinolono junginių gamybos būdas
LTPA2021002C LTC3214083I2 (lt) 2008-09-24 2021-02-17 Kvinolono junginių gamybos būdas

Family Applications Before (2)

Application Number Title Priority Date Filing Date
LTEP20191961.0T LT3766876T (lt) 2008-09-24 2009-09-23 Farmacinė vaisto forma, turinti chinolono darinį
LTEP17163383.7T LT3214083T (lt) 2008-09-24 2009-09-23 Kvinolono junginių gamybos būdas

Country Status (28)

Country Link
US (3) US8497378B2 (lt)
EP (3) EP3766876B8 (lt)
JP (2) JP6013734B2 (lt)
KR (3) KR101775304B1 (lt)
CN (2) CN102164912B (lt)
AU (1) AU2009297085B2 (lt)
BR (1) BRPI0919241B8 (lt)
CA (1) CA2738236C (lt)
CY (2) CY1123658T1 (lt)
DK (2) DK2346855T3 (lt)
ES (3) ES2826273T3 (lt)
FI (2) FI3766876T3 (lt)
HK (1) HK1214243A1 (lt)
HR (1) HRP20201879T1 (lt)
HU (2) HUE052219T2 (lt)
IL (1) IL211845A (lt)
LT (3) LT3766876T (lt)
MX (3) MX2011003122A (lt)
NL (1) NL301091I2 (lt)
NO (1) NO2021006I1 (lt)
PL (2) PL3766876T3 (lt)
PT (1) PT3214083T (lt)
RS (1) RS61194B1 (lt)
RU (1) RU2546667C2 (lt)
SG (1) SG10201605492YA (lt)
SI (1) SI3214083T1 (lt)
SM (1) SMT202000690T1 (lt)
WO (1) WO2010036329A2 (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
PT3214083T (pt) * 2008-09-24 2020-12-04 Melinta Subsidiary Corp Processo de preparação compostos de quinolona
WO2014152317A2 (en) * 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating gonorrhea infections using quinolone antibiotics
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
JP6813665B2 (ja) 2017-03-31 2021-01-13 富士フイルム株式会社 4−ピリドン化合物またはその塩、それを含む医薬組成物および剤
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
ES2200439T3 (es) 1995-09-22 2004-03-01 Wakunaga Pharmaceutical Co., Ltd. Intermedios para utilizar en la preparacion de nuevos derivados del acido piridonocarboxilico o sus sales.
MXPA02000103A (es) * 1999-07-01 2003-07-21 Wakunaga Pharma Co Ltd Derivado de acido quinolin carboxilico o sales del mismo.
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
EP1789392A2 (en) 2004-07-30 2007-05-30 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
US7728143B2 (en) 2004-10-08 2010-06-01 Abbott Laboratories Salt and crystalline forms thereof of a drug
SI1868581T1 (sl) 2005-04-11 2012-06-29 Abbott Lab Farmacevtski sestavki z izboljšanim profilom topnosti za slabo topna zdravila
PT3214083T (pt) 2008-09-24 2020-12-04 Melinta Subsidiary Corp Processo de preparação compostos de quinolona

Also Published As

Publication number Publication date
CN105001207A (zh) 2015-10-28
CY1123658T1 (el) 2021-05-05
EP2346855A2 (en) 2011-07-27
EP3766876B1 (en) 2023-09-13
AU2009297085B2 (en) 2015-07-09
US8497378B2 (en) 2013-07-30
NL301091I2 (nl) 2021-08-03
BRPI0919241B8 (pt) 2021-05-25
FIC20210002I1 (fi) 2021-02-16
PT3214083T (pt) 2020-12-04
RU2011116052A (ru) 2012-10-27
US20120041208A1 (en) 2012-02-16
SMT202000690T1 (it) 2021-01-05
IL211845A0 (en) 2011-06-30
CY2021004I2 (el) 2021-05-05
MX377930B (es) 2025-03-10
FI3766876T3 (fi) 2023-12-05
IL211845A (en) 2017-03-30
KR20110091504A (ko) 2011-08-11
RU2546667C2 (ru) 2015-04-10
CA2738236C (en) 2016-11-15
ES2826273T3 (es) 2021-05-17
EP3214083A1 (en) 2017-09-06
HK1244481A1 (en) 2018-08-10
USRE46617E1 (en) 2017-11-28
US20140171648A1 (en) 2014-06-19
CN102164912B (zh) 2015-08-19
BRPI0919241A8 (pt) 2017-10-17
HRP20201879T1 (hr) 2021-01-22
BRPI0919241A2 (pt) 2016-06-21
NL301091I1 (nl) 2021-02-10
HUS2100004I1 (hu) 2021-03-01
PL3214083T3 (pl) 2021-04-06
HK1214243A1 (zh) 2016-07-22
PL3766876T3 (pl) 2024-04-02
SI3214083T1 (sl) 2021-02-26
EP3214083B1 (en) 2020-09-16
CN102164912A (zh) 2011-08-24
NO2021006I1 (no) 2021-02-15
EP3766876A1 (en) 2021-01-20
US8871938B2 (en) 2014-10-28
LTPA2021002I1 (lt) 2021-03-10
KR20160116020A (ko) 2016-10-06
ES2966093T3 (es) 2024-04-18
BRPI0919241B1 (pt) 2020-05-12
MX2011003122A (es) 2011-07-20
CY2021004I1 (el) 2021-05-05
WO2010036329A3 (en) 2010-07-01
CA2738236A1 (en) 2010-04-01
MX2020009790A (es) 2020-10-12
JP6013734B2 (ja) 2016-10-25
EP3766876B8 (en) 2023-10-18
SG10201605492YA (en) 2016-09-29
EP2346855A4 (en) 2012-07-04
DK2346855T3 (en) 2017-07-24
KR101775304B1 (ko) 2017-09-05
LT3766876T (lt) 2023-12-11
ES2629466T3 (es) 2017-08-09
HUE052219T2 (hu) 2021-04-28
LT3214083T (lt) 2021-01-25
JP2015178515A (ja) 2015-10-08
RS61194B1 (sr) 2021-01-29
AU2009297085A1 (en) 2010-04-01
KR20170039758A (ko) 2017-04-11
EP2346855B1 (en) 2017-04-05
JP2012508161A (ja) 2012-04-05
DK3214083T3 (da) 2020-12-07
WO2010036329A2 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
LTPA2021002I1 (lt) Kvinolono junginių gamybos būdas
BRPI0916499A2 (pt) método de produção de biomassa
FI20095140L (fi) Menetelmä muokatun selluloosan valmistamiseksi
BRPI0919116A2 (pt) método
EP2379160A4 (en) MAKING A PLASTER
PL2560691T3 (pl) Sposób wytwarzania kompozycji immunolobulinowej
PL2743055T3 (pl) Sposób wytwarzania wyrobu
BRPI0920540A2 (pt) método de produção de álcool
BRPI0906098A2 (pt) Método de preparação de um composto
HRP20160404T8 (hr) Metoda za proizvodnju trombocita
EP2374802A4 (en) INHIBITOR OF KYNURENINE PRODUCTION
PL2160432T3 (pl) Sposób wytwarzania poliamidów
PL3299356T3 (pl) Sposób wytwarzania pleuromutylin
BRPI0922490A2 (pt) Método para produção de beta-santaleno
DK2313489T3 (da) Fremstillingsmetode
BR112013016073A2 (pt) método para produçao de compostos orgânicos
DK2346661T3 (da) Dannelsesfremgangsmåder
BR112012014162A2 (pt) método de fabricação de uma nanomanta
BRPI0923001A2 (pt) método de produção de lipossomas pequenos
PL2358641T3 (pl) Sposób wytwarzania tytanianów
EP2233612A4 (en) ELECTROLYSIS PROCESS
BRPI0916597A2 (pt) Método
PL2440509T3 (pl) Sposób wytwarzania heksafluoropropanu
EP2321435A4 (en) WIEDERAUFKOHLUNGSVERFAHREN
IS8917A (is) Aðferð til að smíða skó